These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3439364)

  • 21. Efficacy of anti-CD20 treatment in patients with rheumatoid arthritis resistant to a combination of methotrexate/anti-TNF therapy.
    Bokarewa M; Lindholm C; Zendjanchi K; Nadali M; Tarkowski A
    Scand J Immunol; 2007 Oct; 66(4):476-83. PubMed ID: 17850593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [FDDF (fast dissolving dosage form) piroxicam for sublingual administration in the treatment of rheumatoid arthritis].
    Montecucco C; Caporali R; Ronchetti A; Rossi S; Comaschi E
    Minerva Med; 1994 Dec; 85(12):633-8. PubMed ID: 7854556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse.
    Cambridge G; Stohl W; Leandro MJ; Migone TS; Hilbert DM; Edwards JC
    Arthritis Rheum; 2006 Mar; 54(3):723-32. PubMed ID: 16508933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment with low-dose methotrexate in chronic polyarthritis. Review of the literature].
    Rau R
    Z Rheumatol; 1986; 45(6):283-95. PubMed ID: 3548154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effectiveness of plasma exchange therapy in patients with rheumatoid arthritis and systemic manifestations].
    Achenbach H; Häntzschel H; Würzberger G; Seidel W; Otto W
    Z Gesamte Inn Med; 1986 Mar; 41(6):174-6. PubMed ID: 3716511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy, tolerability and safety of cyclosporine for microemulsion in the treatment of active rheumatoid arthritis. Open study].
    Marcos JC; Maccagno A; Gutfraind E; Garsd A; Messina DO; Maldonado Cocco J; Battagliotti C; Onetti CM; Tate G; Venarotti HO; Grosman H; Díaz EA; Otero AB
    Medicina (B Aires); 2000; 60(4):435-40. PubMed ID: 11188947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of D-penicillamine on lymphocyte subsets: correlation with clinical response in rheumatoid arthritis.
    Singh RR; Malaviya AN; Malaviya R; Sharma M; Shandilya R; Taneja V; Khare SD; Beri D; Kumar A; Mehra NK
    J Assoc Physicians India; 1994 Mar; 42(3):201-4. PubMed ID: 7860508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased suppressive B cell factor (SBF) in rheumatoid arthritis: evidence for a defect in B cell autoregulation.
    White RE; Pisko EJ; Foster SL; Panetti M; Turner RA
    J Immunol; 1986 Mar; 136(6):2151-7. PubMed ID: 3485142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rheumatoid factor by laser nephelometry and Waaler-Rose assay: prognostic value in patients with recent-onset rheumatoid arthritis.
    Nikolaisen C; Rekvig OP; Nossent HC
    Scand J Rheumatol; 2005; 34(4):269-76. PubMed ID: 16195159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Titration of infliximab treatment in rheumatoid arthritis patients based on response patterns.
    Flendrie M; Creemers MC; van Riel PL
    Rheumatology (Oxford); 2007 Jan; 46(1):146-9. PubMed ID: 16782732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 10 year prospective followup of patients with rheumatoid arthritis 1986-96.
    Gordon P; West J; Jones H; Gibson T
    J Rheumatol; 2001 Nov; 28(11):2409-15. PubMed ID: 11708411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of a sixteen-week training program on strength, pain, and function in rheumatoid arthritis patients.
    Flint-Wagner HG; Lisse J; Lohman TG; Going SB; Guido T; Cussler E; Gates D; Yocum DE
    J Clin Rheumatol; 2009 Jun; 15(4):165-71. PubMed ID: 19279507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of rheumatoid arthritis with a DR4/1 peptide.
    St Clair EW; Cohen SB; Lee ML; Fleischmann RM; Lee SH; Moreland LW; Olsen NJ; Pratt PW; Yocum DE; Heck L; Winkelhake J; Holcenberg JS; Shulman MJ
    J Rheumatol; 2000 Aug; 27(8):1855-63. PubMed ID: 10955324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Filtration leukocytapheresis therapy in rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial.
    Hidaka T; Suzuki K; Matsuki Y; Takamizawa-Matsumoto M; Kataharada K; Ishizuka T; Kawakami M; Nakamura H
    Arthritis Rheum; 1999 Mar; 42(3):431-7. PubMed ID: 10088764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Enzyme therapy in comparison with immune complex determinations in chronic polyarthritis].
    Steffen C; Smolen J; Miehlke K; Hörger I; Menzel J
    Z Rheumatol; 1985; 44(2):51-6. PubMed ID: 4050140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In active chronic rheumatoid arthritis, dipeptidyl peptidase IV density is increased on monocytes and CD4(+) T lymphocytes.
    Ellingsen T; Hornung N; Møller BK; Hjelm-Poulsen J; Stengaard-Pedersen K
    Scand J Immunol; 2007 Oct; 66(4):451-7. PubMed ID: 17850590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of rheumatoid polyarthritis with methotrexate in Dakar: efficacy, tolerance and cost].
    Ka MM; Diallo S; Ka EF; Diop BM; Pouye A; Mbengue M; Leye A; Diouf B; Diop TM
    Sante; 2000; 10(1):65-8. PubMed ID: 10827366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Prosorba column for treatment of refractory rheumatoid arthritis: a randomized, double-blind, sham-controlled trial.
    Felson DT; LaValley MP; Baldassare AR; Block JA; Caldwell JR; Cannon GW; Deal C; Evans S; Fleischmann R; Gendreau RM; Harris ER; Matteson EL; Roth SH; Schumacher HR; Weisman MH; Furst DE
    Arthritis Rheum; 1999 Oct; 42(10):2153-9. PubMed ID: 10524687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological studies in patients with rheumatoid arthritis treated with methotrexate or cyclophosphamide.
    Lacki JK; Schochat T; Sobieska M; Leszczynski P; Wiktorowicz K; Mackiewicz U; Mackiewicz SH; Müller W
    Z Rheumatol; 1994; 53(2):76-82. PubMed ID: 8023589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.